1
|
Grent-'t-Jong T, Brickwedde M, Metzner C, Uhlhaas PJ. 40-Hz Auditory Steady-State Responses in Schizophrenia: Toward a Mechanistic Biomarker for Circuit Dysfunctions and Early Detection and Diagnosis. Biol Psychiatry 2023; 94:550-560. [PMID: 37086914 DOI: 10.1016/j.biopsych.2023.03.026] [Citation(s) in RCA: 8] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/15/2023] [Revised: 03/21/2023] [Accepted: 03/30/2023] [Indexed: 04/24/2023]
Abstract
There is converging evidence that 40-Hz auditory steady-state responses (ASSRs) are robustly impaired in schizophrenia and could constitute a potential biomarker for characterizing circuit dysfunctions as well as enable early detection and diagnosis. Here, we provide an overview of the mechanisms involved in 40-Hz ASSRs, drawing on computational, physiological, and pharmacological data with a focus on parameters modulating the balance between excitation and inhibition. We will then summarize findings from electro- and magnetoencephalographic studies in participants at clinical high risk for psychosis, patients with first-episode psychosis, and patients with schizophrenia to identify the pattern of deficits across illness stages, the relationship with clinical variables, and the prognostic potential. Finally, data on genetics and developmental modifications will be reviewed, highlighting the importance of late modifications of 40-Hz ASSRs during adolescence, which are closely related to the underlying changes in GABA (gamma-aminobutyric acid) interneurons. Together, our review suggests that 40-Hz ASSRs may constitute an informative electrophysiological approach to characterize circuit dysfunctions in psychosis that could be relevant for the development of mechanistic biomarkers.
Collapse
Affiliation(s)
- Tineke Grent-'t-Jong
- Department of Child and Adolescent Psychiatry, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Marion Brickwedde
- Department of Child and Adolescent Psychiatry, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
| | - Christoph Metzner
- Department of Child and Adolescent Psychiatry, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Neural Information Processing Group, Institute of Software Engineering and Theoretical Computer Science, Technische Universität Berlin, Berlin, Germany; School of Physics, Engineering and Computer Science, University of Hertfordshire, Hatfield, United Kingdom
| | - Peter J Uhlhaas
- Department of Child and Adolescent Psychiatry, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Institute of Neuroscience and Psychology, University of Glasgow, Glasgow, United Kingdom.
| |
Collapse
|
2
|
Isler JR, Pini N, Lucchini M, Shuffrey LC, Morales S, Bowers ME, Leach SC, Sania A, Wang L, Condon C, Nugent JD, Elliott AJ, Friedrich C, Andrew R, Fox NA, Myers MM, Fifer WP. Longitudinal characterization of EEG power spectra during eyes open and eyes closed conditions in children. Psychophysiology 2023; 60:e14158. [PMID: 35968705 PMCID: PMC9729391 DOI: 10.1111/psyp.14158] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2021] [Revised: 05/18/2022] [Accepted: 07/11/2022] [Indexed: 11/28/2022]
Abstract
This study is the first to examine spectrum-wide (1 to 250 Hz) differences in electroencephalogram (EEG) power between eyes open (EO) and eyes closed (EC) resting state conditions in 486 children. The results extend the findings of previous studies by characterizing EEG power differences from 30 to 250 Hz between EO and EC across childhood. Developmental changes in EEG power showed spatial and frequency band differences as a function of age and EO/EC condition. A 64-electrode system was used to record EEG at 4, 5, 7, 9, and 11 years of age. Specific findings were: (1) the alpha peak shifts from 8 Hz at 4 years to 9 Hz at 11 years, (2) EC results in increased EEG power (compared to EO) at lower frequencies but decreased EEG power at higher frequencies for all ages, (3) the EEG power difference between EO and EC changes from positive to negative within a narrow frequency band which shifts toward higher frequencies with age, from 9 to 12 Hz at 4 years to 32 Hz at 11 years, (4) at all ages EC is characterized by an increase in lower frequency EEG power most prominently over posterior regions, (5) at all ages, during EC, decreases in EEG power above 30 Hz are mostly over anterior regions of the scalp. This report demonstrates that the simple challenge of opening and closing the eyes offers the potential to provide quantitative biomarkers of phenotypic variation in brain maturation by employing a brief, minimally invasive protocol throughout childhood.
Collapse
Affiliation(s)
- J. R. Isler
- Department of Pediatrics, Columbia University Irving Medical Center, New York, NY 10032 USA
| | - N. Pini
- Department of Psychiatry, Columbia University Irving Medical Center, New York, NY 10032 USA
- Division of Developmental Neuroscience, New York State Psychiatric Institute, New York, NY 10032 USA
| | - M. Lucchini
- Department of Psychiatry, Columbia University Irving Medical Center, New York, NY 10032 USA
- Division of Developmental Neuroscience, New York State Psychiatric Institute, New York, NY 10032 USA
| | - L. C. Shuffrey
- Department of Psychiatry, Columbia University Irving Medical Center, New York, NY 10032 USA
- Division of Developmental Neuroscience, New York State Psychiatric Institute, New York, NY 10032 USA
| | - S. Morales
- Department of Psychology, University of Southern California, Los Angeles, CA 90089 USA
| | - M. E. Bowers
- Department of Human Development and Quantitative Methodology, University of Maryland, College Park, MD 20742 USA
| | - S. C. Leach
- Department of Human Development and Quantitative Methodology, University of Maryland, College Park, MD 20742 USA
| | - A. Sania
- Department of Psychiatry, Columbia University Irving Medical Center, New York, NY 10032 USA
- Division of Developmental Neuroscience, New York State Psychiatric Institute, New York, NY 10032 USA
| | - L. Wang
- Division of Developmental Neuroscience, New York State Psychiatric Institute, New York, NY 10032 USA
- Data Science Institute, Columbia University, New York, NY 10027 USA
| | - C. Condon
- Division of Developmental Neuroscience, New York State Psychiatric Institute, New York, NY 10032 USA
| | - J. D. Nugent
- Division of Developmental Neuroscience, New York State Psychiatric Institute, New York, NY 10032 USA
| | | | - C. Friedrich
- Avera Research Institute, Sioux Falls, SD 57108 USA
| | - R. Andrew
- Avera Research Institute, Sioux Falls, SD 57108 USA
| | - N. A. Fox
- Department of Human Development and Quantitative Methodology, University of Maryland, College Park, MD 20742 USA
| | - M. M. Myers
- Department of Pediatrics, Columbia University Irving Medical Center, New York, NY 10032 USA
- Department of Psychiatry, Columbia University Irving Medical Center, New York, NY 10032 USA
- Division of Developmental Neuroscience, New York State Psychiatric Institute, New York, NY 10032 USA
| | - W. P. Fifer
- Department of Pediatrics, Columbia University Irving Medical Center, New York, NY 10032 USA
- Department of Psychiatry, Columbia University Irving Medical Center, New York, NY 10032 USA
- Division of Developmental Neuroscience, New York State Psychiatric Institute, New York, NY 10032 USA
| |
Collapse
|
3
|
Li Y, Wang X, Li Z, Chen J, Qin L. Effect of locomotion on the auditory steady state response of head-fixed mice. World J Biol Psychiatry 2021; 22:362-372. [PMID: 32901530 DOI: 10.1080/15622975.2020.1814409] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
OBJECTIVES Electroencephalographic (EEG) examinations of the auditory steady-state response (ASSR) can non-invasively probe cortical function to generate the gamma-band (40 Hz) oscillation, which is increasingly applied to the neurophysiological studies on the rodent models of psychiatric disorders. Though, it has been well established that the brain activities are significantly modulated by the behavioural state (such as locomotion), how the ASSR is affected remains unclear. METHODS We investigated the effect of locomotion by recording local field potential (LFP) evoked by 40-Hz click-train from multiple brain areas: auditory cortex (AC), medial geniculate body (MGB), hippocampus (HP) and prefrontal cortex (PFC), in head-fixed mice free to run on a treadmill. Comparisons were conducted on the LFPs during spontaneous movement and stationary conditions. RESULTS We found that in both the auditory (AC and MGB) and non-auditory areas (HP and PFC), locomotion reduced the initial negative deflection of LFP (early response during 0-100 ms from stimulus onset), and had no significant effect on the ASSR phase-locking to the late stimulus (100-500 ms). CONCLUSIONS Our results suggest that different neural mechanisms contribute to the early response and ASSR, and the ASSR is a more robust biomarker to investigate the pathogenesis of neuropsychiatric disorders.
Collapse
Affiliation(s)
- Yingzhuo Li
- Department of Physiology, China Medical University, Shenyang, PR China
| | - Xuejiao Wang
- Department of Physiology, China Medical University, Shenyang, PR China
| | - Zijie Li
- Department of Physiology, China Medical University, Shenyang, PR China
| | - Jingyu Chen
- Department of Physiology, China Medical University, Shenyang, PR China
| | - Ling Qin
- Department of Physiology, China Medical University, Shenyang, PR China
| |
Collapse
|
4
|
Parciauskaite V, Bjekic J, Griskova-Bulanova I. Gamma-Range Auditory Steady-State Responses and Cognitive Performance: A Systematic Review. Brain Sci 2021; 11:217. [PMID: 33579014 PMCID: PMC7916793 DOI: 10.3390/brainsci11020217] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2020] [Revised: 01/22/2021] [Accepted: 02/07/2021] [Indexed: 12/14/2022] Open
Abstract
The auditory steady-state response (ASSR) is a result of entrainment of the brain's oscillatory activity to the frequency and phase of temporally modulated stimuli. Gamma-range ASSRs are utilized to observe the dysfunctions of brain-synchronization abilities in neuropsychiatric and developmental disorders with cognitive symptoms. However, the link between gamma-range ASSRs and cognitive functioning is not clear. We systematically reviewed existing findings on the associations between gamma-range ASSRs and cognitive functions in patients with neuropsychiatric or developmental disorders and healthy subjects. The literature search yielded 1597 articles. After excluding duplicates and assessing eligibility, 22 articles were included. In healthy participants, the gamma-range ASSR was related to cognitive flexibility and reasoning as measured by complex tasks and behavioral indicators of processing speed. In patients with schizophrenia, the studies that reported correlations found a higher ASSR to be accompanied by better performance on short-term memory tasks, long-term/semantic memory, and simple speeded tasks. The main findings indicate that individual differences in the gamma-range ASSR reflect the level of attentional control and the ability to temporary store and manipulate the information, which are necessary for a wide range of complex cognitive activities, including language, in both healthy and impaired populations.
Collapse
Affiliation(s)
- Vykinta Parciauskaite
- Life Sciences Centre, Institute of Biosciences, Vilnius University, Sauletekio ave 7, LT-10257 Vilnius, Lithuania;
| | - Jovana Bjekic
- Human Neuroscience Group, Institute for Medical Research, University of Belgrade, Dr Subotića 4, 11000 Belgrade, Serbia;
| | - Inga Griskova-Bulanova
- Life Sciences Centre, Institute of Biosciences, Vilnius University, Sauletekio ave 7, LT-10257 Vilnius, Lithuania;
| |
Collapse
|
5
|
Griskova-Bulanova I, Voicikas A, Dapsys K, Melynyte S, Andruskevicius S, Pipinis E. Envelope Following Response to 440 Hz Carrier Chirp-Modulated Tones Show Clinically Relevant Changes in Schizophrenia. Brain Sci 2020; 11:brainsci11010022. [PMID: 33375449 PMCID: PMC7824599 DOI: 10.3390/brainsci11010022] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2020] [Revised: 12/20/2020] [Accepted: 12/24/2020] [Indexed: 12/16/2022] Open
Abstract
The 40 Hz auditory steady-state response (ASSR) impairment is suggested as an electrophysiological biomarker of schizophrenia; however, existing data also points to the deficiency of low and high frequency ASSR responses. In order to obtain the full picture of potential impairment in schizophrenia, it is important to test responses at different frequencies. The current study aims to evaluate a wide frequency range (1-120 Hz) in response to brief low-frequency carrier chirp-modulated tones in a group of patients with schizophrenia. The EEG-derived envelope following responses (EFRs) were obtained in a group of male patients with schizophrenia (N = 18) and matched controls (N = 18). While subjects were watching silent movies, 440 Hz carrier chirp-modulated at 1-120 Hz tones were presented. Phase-locking index and evoked amplitude in response to stimulation were assessed and compared on point-to-point basis. The peak frequency of the low gamma response was estimated. Measures were correlated with psychopathology-positive, negative, total scores of the Positive and Negative Syndrome Scale (PANSS), and hallucination subscale scores. In comparison to controls, patients showed (1) reduced power of theta-beta (4-18 Hz) responses, (2) intact but slower low gamma (30-60 Hz), and (3) reduced high gamma (95-120 Hz) responses. No correlation survived the Bonferroni correction, but a sign of positive association between low gamma phase-locking and the prevalence of hallucinations, and a sign of negative association between high gamma phase-locking and the total PANSS scores were observed. Brain networks showed impaired capabilities to generate EFRs at different frequencies in schizophrenia; moreover, even when responses of patients did not significantly differ from controls on the group level, they still showed potentially clinically relevant variability.
Collapse
Affiliation(s)
- Inga Griskova-Bulanova
- Institute of Biosciences, Life Sciences Centre, Vilnius University, Saulėtekio av. 7, LT-10257 Vilnius, Lithuania; (K.D.); (S.M.); (E.P.)
- Correspondence: ; Tel.: +370-67110954
| | - Aleksandras Voicikas
- Vilnius Republican Psychiatric Hospital, Parko str. 21, LT-11205 Vilnius, Lithuania; (A.V.); (S.A.)
| | - Kastytis Dapsys
- Institute of Biosciences, Life Sciences Centre, Vilnius University, Saulėtekio av. 7, LT-10257 Vilnius, Lithuania; (K.D.); (S.M.); (E.P.)
- Vilnius Republican Psychiatric Hospital, Parko str. 21, LT-11205 Vilnius, Lithuania; (A.V.); (S.A.)
| | - Sigita Melynyte
- Institute of Biosciences, Life Sciences Centre, Vilnius University, Saulėtekio av. 7, LT-10257 Vilnius, Lithuania; (K.D.); (S.M.); (E.P.)
| | - Sergejus Andruskevicius
- Vilnius Republican Psychiatric Hospital, Parko str. 21, LT-11205 Vilnius, Lithuania; (A.V.); (S.A.)
- Institute of Psychology, Mykolas Romeris University, Ateities str. 20, LT-08303 Vilnius, Lithuania
| | - Evaldas Pipinis
- Institute of Biosciences, Life Sciences Centre, Vilnius University, Saulėtekio av. 7, LT-10257 Vilnius, Lithuania; (K.D.); (S.M.); (E.P.)
| |
Collapse
|
6
|
Kozono N, Honda S, Tada M, Kirihara K, Zhao Z, Jinde S, Uka T, Yamada H, Matsumoto M, Kasai K, Mihara T. Auditory Steady State Response; nature and utility as a translational science tool. Sci Rep 2019; 9:8454. [PMID: 31186500 PMCID: PMC6560088 DOI: 10.1038/s41598-019-44936-3] [Citation(s) in RCA: 26] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2018] [Accepted: 05/29/2019] [Indexed: 01/28/2023] Open
Abstract
The auditory steady-state response (ASSR) has been used to detect auditory processing deficits in patients with psychiatric disorders. However, the methodology of ASSR recording from the brain surface has not been standardized in preclinical studies, limiting its use as a translational biomarker. The sites of maximal ASSR in humans are the vertex and/or middle frontal area, although it has been suggested that the auditory cortex is the source of the ASSR. We constructed and validated novel methods for ASSR recording using a switchable pedestal which allows ASSR recording alternatively from temporal or parietal cortex with a wide range of frequencies in freely moving rats. We further evaluated ASSR as a translational tool by assessing the effect of ketamine. The ASSR measured at parietal cortex did not show clear event-related spectral perturbation (ERSP) or inter-trial coherence (ITC) in any frequency bands or a change with ketamine. In contrast, the ASSR at temporal cortex showed clear ERSP and ITC where 40 Hz was maximal in both gamma-band frequencies. Ketamine exerted a biphasic effect in ERSP at gamma bands. These findings suggest that temporal cortex recording with a wide frequency range is a robust methodology to detect ASSR, potentially enabling application as a translational biomarker in psychiatric and developmental disorders.
Collapse
Affiliation(s)
- Naoki Kozono
- Candidate Discovery Science Labs., Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba-shi, Ibaraki, 305-8585, Japan
| | - Sokichi Honda
- Candidate Discovery Science Labs., Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba-shi, Ibaraki, 305-8585, Japan
| | - Mariko Tada
- Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.,International Research Center for Neurointelligence (WPI-IRCN), UTIAS, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan
| | - Kenji Kirihara
- Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan
| | - Zhilei Zhao
- Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.,International Research Center for Neurointelligence (WPI-IRCN), UTIAS, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan
| | - Seiichiro Jinde
- Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan
| | - Takanori Uka
- Department of Integrative Physiology, Graduate School of Medicine, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi, 409-3898, Japan
| | - Hiroshi Yamada
- Candidate Discovery Science Labs., Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba-shi, Ibaraki, 305-8585, Japan
| | - Mitsuyuki Matsumoto
- Candidate Discovery Science Labs., Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba-shi, Ibaraki, 305-8585, Japan
| | - Kiyoto Kasai
- Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.,International Research Center for Neurointelligence (WPI-IRCN), UTIAS, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan
| | - Takuma Mihara
- Candidate Discovery Science Labs., Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba-shi, Ibaraki, 305-8585, Japan.
| |
Collapse
|
7
|
Wang J, Tang Y, Curtin A, Chan RCK, Wang Y, Li H, Zhang T, Qian Z, Guo Q, Li Y, Liu X, Tang X, Wang J. Abnormal auditory-evoked gamma band oscillations in first-episode schizophrenia during both eye open and eye close states. Prog Neuropsychopharmacol Biol Psychiatry 2018; 86:279-286. [PMID: 29705712 DOI: 10.1016/j.pnpbp.2018.04.016] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/19/2017] [Revised: 03/28/2018] [Accepted: 04/25/2018] [Indexed: 12/20/2022]
Abstract
Abnormal auditory steady state response (ASSR) is a typical finding among schizophrenia patients, which is thought to directly reflect deficient gamma band oscillations in the brain. However, whether these ASSR alterations are state dependent, e.g. during eye-open or eye-closed conditions, has not yet been carefully elucidated in schizophrenia. Our study aimed to explore whether the abnormality of ASSR in patients with first-episode schizophrenia (FEP) is altered under eye-open (EO) and eye-closed (EC) states. ASSR was elicited using 40 Hz click trains under EO and EC states. Twenty-eight healthy control subjects (HC) and thirty-three FEP individuals, 17 of whom were medication-naïve, were recruited. The event-related spectrum perturbation (ERSP) and intertrial coherence (ITC) in response to 40 Hz click sounds were quantified. Compared to HC group, FEP group showed a lower ITC and ERSP during EO state, as well as a decreased ITC during EC state. Our results suggest that abnormalities in gamma band oscillations among first-episode schizophrenia patients are present under both eye open and eye close states. Although differences in gamma band oscillations between EO and EC states within the FEP group were not observed, exploratory results suggest that state-sensitivity may be contingent on medication use.
Collapse
Affiliation(s)
- Junjie Wang
- Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai 200030, China
| | - Yingying Tang
- Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai 200030, China.
| | - Adrian Curtin
- School of Biomedical Engineering & Health Sciences, Drexel University, Philadelphia, PA 19104, USA; Med-X Institute, Shanghai Jiaotong University University, Shanghai 200300, China
| | - Raymond C K Chan
- Neuropsychology and Applied Cognitive Neuroscience Laboratory, CAS Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing 100101, China; Department of Psychology, University of Chinese Academy of Sciences, Beijing, China
| | - Ya Wang
- Neuropsychology and Applied Cognitive Neuroscience Laboratory, CAS Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing 100101, China; Department of Psychology, University of Chinese Academy of Sciences, Beijing, China
| | - Hui Li
- Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai 200030, China
| | - Tianhong Zhang
- Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai 200030, China
| | - Zhenying Qian
- Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai 200030, China
| | - Qian Guo
- Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai 200030, China
| | - Yu Li
- Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai 200030, China
| | - Xu Liu
- Institute of Neuroscience, State Key Laboratory of Neuroscience, Key Laboratory of Primate Neurobiology, Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai 200031, China; University of Chinese Academy of Sciences, Shanghai 200031, China
| | - Xiaochen Tang
- Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai 200030, China
| | - Jijun Wang
- Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai 200030, China; CAS Center for Excellence in Brain Science and Intelligence Technology (CEBSIT), Chinese Academy of Science, China; Brain Science and Technology Research Center, Shanghai Jiaotong University, Shanghai 200030, China; Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiaotong University, Shanghai 200030, China.
| |
Collapse
|
8
|
Griskova-Bulanova I, Hubl D, van Swam C, Dierks T, Koenig T. Early- and late-latency gamma auditory steady-state response in schizophrenia during closed eyes: Does hallucination status matter? Clin Neurophysiol 2016; 127:2214-21. [PMID: 27072092 DOI: 10.1016/j.clinph.2016.02.009] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2015] [Revised: 02/11/2016] [Accepted: 02/12/2016] [Indexed: 12/15/2022]
Abstract
OBJECTIVES Auditory steady-state responses are larger in patients experiencing auditory verbal hallucinations (AVH) than in never hallucinating subjects (NH) when recorded with open eyes. Compensatory effects were shown for schizophrenic patients when recorded with closed eyes. This effect has not been evaluated in respect to hallucination status. METHODS Gamma responses to 40Hz stimulation were recorded in 15AVH patients, 25 healthy controls and 11NH patients with closed eyes. Mean and peak evoked amplitude and phase-locking index, peak time and maximal frequency were extracted for early- and late-latency responses and compared between groups. RESULTS Phase-locking of early, but not late-latency gamma was diminished in schizophrenic patients independently on hallucination status. Peak entrainment time was delayed in hallucinating patients. Magnitude and frequency of early-latency response correlated to negative symptoms. CONCLUSIONS In AVH patients, entrainment at gamma frequency was "normal" when eyes were closed. In contrast to never hallucinating subjects, entrainment to stimulation was delayed in AVH. The early-latency gamma response, standing for early sensory stimulus processing, on the contrary, was impaired in SZ irrespective of prevalence of hallucinations and was not modulated by subjects' general state; however its magnitude might be related to the expression of negative symptomatology. SIGNIFICANCE Evaluation of auditory entrainment in both open eyes and closed eyes conditions is informative. Frequency and timing information of both early-latency and late-latency responses helps to uncover different aspects of impairment in schizophrenia patients.
Collapse
Affiliation(s)
- Inga Griskova-Bulanova
- Department of Neurobiology and Biophysics, Vilnius University, Vilnius, Lithuania; Republican Vilnius Psychiatric Hospital, Vilnius, Lithuania.
| | - Daniela Hubl
- Translational Research Center, University Hospital of Psychiatry, University of Bern, Switzerland
| | - Claudia van Swam
- Translational Research Center, University Hospital of Psychiatry, University of Bern, Switzerland
| | - Thomas Dierks
- Translational Research Center, University Hospital of Psychiatry, University of Bern, Switzerland
| | - Thomas Koenig
- Translational Research Center, University Hospital of Psychiatry, University of Bern, Switzerland
| |
Collapse
|
9
|
Silverstein SM, Wang Y, Keane BP. Cognitive and neuroplasticity mechanisms by which congenital or early blindness may confer a protective effect against schizophrenia. Front Psychol 2013; 3:624. [PMID: 23349646 PMCID: PMC3552473 DOI: 10.3389/fpsyg.2012.00624] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2012] [Accepted: 12/31/2012] [Indexed: 12/12/2022] Open
Abstract
Several authors have noted that there are no reported cases of people with schizophrenia who were born blind or who developed blindness shortly after birth, suggesting that congenital or early (C/E) blindness may serve as a protective factor against schizophrenia. By what mechanisms might this effect operate? Here, we hypothesize that C/E blindness offers protection by strengthening cognitive functions whose impairment characterizes schizophrenia, and by constraining cognitive processes that exhibit excessive flexibility in schizophrenia. After briefly summarizing evidence that schizophrenia is fundamentally a cognitive disorder, we review areas of perceptual and cognitive function that are both impaired in the illness and augmented in C/E blindness, as compared to healthy sighted individuals. We next discuss: (1) the role of neuroplasticity in driving these cognitive changes in C/E blindness; (2) evidence that C/E blindness does not confer protective effects against other mental disorders; and (3) evidence that other forms of C/E sensory loss (e.g., deafness) do not reduce the risk of schizophrenia. We conclude by discussing implications of these data for designing cognitive training interventions to reduce schizophrenia-related cognitive impairment, and perhaps to reduce the likelihood of the development of the disorder itself.
Collapse
Affiliation(s)
- Steven M. Silverstein
- University Behavioral HealthCare, University of Medicine and Dentistry of New JerseyPiscataway, NJ, USA
- Department of Psychiatry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical SchoolPiscataway, NJ, USA
| | - Yushi Wang
- University Behavioral HealthCare, University of Medicine and Dentistry of New JerseyPiscataway, NJ, USA
| | - Brian P. Keane
- University Behavioral HealthCare, University of Medicine and Dentistry of New JerseyPiscataway, NJ, USA
- Department of Psychiatry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical SchoolPiscataway, NJ, USA
- Rutgers University Center for Cognitive SciencePiscataway, NJ, USA
| |
Collapse
|